ChemAbout
© 2026 ChemAbout
Insights|Política de Privacidade|Termos de Uso|[email protected]
Início/Compostos/Ingrediente ativo (API)/Liraglutide
C172H265N43O51
3751 g/mol
Ingrediente ativo (API)Atenção

Liraglutide

CAS204656-20-2
Categoria
Ingrediente ativo (API)
Classe do Composto
Peptídeo
Uso Principal
Matéria-prima farmacêutica

Liraglutide is a pharmaceutical raw material used in the manufacturing of anti-diabetic medications. It is a synthetic peptide compound consisting of 33 amino acids with a fatty acid side chain, designed for use in research and production of treatments targeting type 2 diabetes and obesity.

active pharmaceutical ingredient for anti-diabetic formulationsresearch compound for metabolic disease studies

Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.

Adquirindo ou fornecendo este composto?

Publique seu inventário ou uma solicitação de compra

CAS 204656-20-2

Publicar este produto
Faça login para publicar informações de fornecimento
Solicitar este produto
Envie uma solicitação sem se registrar

Compostos relacionados

ForteEstrutura similarSimilaridade 0.87

Glucagon-like peptide 1 (1-37)

CAS87805-34-3

active pharmaceutical ingredient

SimilarEstrutura similarSimilaridade 0.84

Semaglutida

CAS910463-68-2

active pharmaceutical ingredient

SimilarEstrutura similarSimilaridade 0.84

GLP-1 (1-36) amide (human, bovine, guinea pig, mouse, rat) trifluoroacetate salt H-His-Asp-Glu-Phe-Glu-Arg-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2 trifluoroacetate salt

CAS99658-04-5

active pharmaceutical ingredient

SimilarEstrutura similarSimilaridade 0.76

Teduglutide

CAS197922-42-2

active pharmaceutical ingredient

ReferênciaMesma categoria

Valerianol

CAS20489-45-6

plant metabolite reference standard

ReferênciaMesma categoria

(R,R)-Epoxy Leucine Carfilzomib

CAS2049025-76-3

proteasome inhibitor impurity reference standard

ReferênciaMesma categoria

Quinapyramine

CAS20493-41-8

veterinary trypanocidal agent

ReferênciaMesma categoria

Upadacitinib hemihydrate

CAS2050057-56-0

active pharmaceutical ingredient

Referência de Segurança

Risco à saúde
Risco à saúde
Atenção
H351Suspected of causing cancer
H361Suspected of damaging fertility or the unborn child
Identificadores
Nome IUPAC

(2S)-5-[[(5S)-5-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-4-carboxybutanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-4-carboxybutanoyl]amino]acetyl]amino]-5-oxopentanoyl]amino]propanoyl]amino]propanoyl]amino]-6-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-carbamimidamido-1-[[2-[[(2S)-5-carbamimidamido-1-(carboxymethylamino)-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-6-oxohexyl]amino]-2-(hexadecanoylamino)-5-oxopentanoic acid

InChIKey

YSDQQAXHVYUZIW-QCIJIYAXSA-N

SMILES

CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N)C(=O)O

Sinônimos (19)
  • Liraglutida [INN-Spanish]
  • Liraglutidum [INN-Latin]
  • Liraglutida
  • Liraglutide
  • Liraglutide (rDNA origin)
  • Liraglutide recombinant
  • Liraglutidum
  • NNC 90-1170
  • Saxenda
  • victoza